Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Clinical and Translational Science|July 2, 2024
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomesVincent Aranzana-Climent, Wisse van Os, Amir Nutman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2018
The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective StudyYael Zak-Doron, Yael Dishon Benattar, Iris Pfeffer, et al.
Antibiotics (Basel, Switzerland)|September 28, 2024
Assessment of De-Escalation of Empirical Antimicrobial Therapy in Medical Wards with Recognized Prevalence of Multi-Drug-Resistant Pathogens: A Multicenter Prospective Cohort Study in Non-ICU Patients with Microbiologically Documented InfectionVasiliki Rapti, Garyfallia Poulakou, Anastasia Mousouli, et al.
BMJ Open|September 24, 2013
Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trialAndie S Lee, Ben S Cooper, Surbhi Malhotra-Kumar, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2026
Comparative effectiveness of two antimicrobial regimens for the treatment of pan-drug-resistant Acinetobacter baumannii infections: results from the DESPAIR studyKonstantinos Pontikis, Ilias Karaiskos, Aikaterini Sakagianni, et al.
International Journal of Antimicrobial Agents|August 11, 2014
Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpointsMaria N Gamaletsou, George L Daikos, Thomas J Walsh, et al.
Human Vaccines & Immunotherapeutics|January 28, 2026
The impact of pneumococcal conjugate vaccines on disease epidemiology, serotype distribution, and antimicrobial resistance in children. A 25-year observational study in Athens, Greece (1996-2021)Vasiliki P Syriopoulou, George L Daikos, Emmanouil I Koutouzis, et al.
Pharmacotherapy|February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant Acinetobacter baumannii cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant OrganismsYaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
Pageof 11